Eurosurv. An outbreak of influenza A(H1N1)pdm09 antigenic variants exhibiting cross-resistance to oseltamivir and peramivir in an elementary school in

[tetano]

• Emi Takashita[SUP]1,*[/SUP] , Kohei Shimizu[SUP]2,*[/SUP] , Shuzo Usuku[SUP]2[/SUP] , Ryuichi Senda[SUP]2[/SUP] , Ichiro Okubo[SUP]2[/SUP] , Hiroko Morita[SUP]1[/SUP] , Shiho Nagata[SUP]1[/SUP] , Seiichiro Fujisaki[SUP]1[/SUP] , Hideka Miura[SUP]1[/SUP] , Noriko Kishida[SUP]1[/SUP] , Kazuya Nakamura[SUP]1[/SUP] , Masayuki Shirakura[SUP]1[/SUP] , Masataka Ichikawa[SUP]3[/SUP] , Yoko Matsuzaki[SUP]4[/SUP] , Shinji Watanabe[SUP]1[/SUP] , Yoshimasa Takahashi[SUP]5[/SUP] , Hideki Hasegawa[SUP]1[/SUP]

An outbreak of influenza A(H1N1)pdm09 viruses exhibiting cross-resistance to oseltamivir and peramivir occurred in Yokohama, Japan, in September 2024. Among 24 students in a class, 11 were diagnosed with influenza or influenza-like illness, and viruses harbouring the NA H275Y and HA Q210H substitutions were isolated from four. Deep sequencing analysis confirmed the clonal spread of these mutants. Antigenic analysis revealed differences from the vaccine strain. Continued monitoring is crucial to assess the potential for further spread of these mutant viruses.


https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2024.29.50.2400786


​